Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Objectives. To evaluate the risk of serious infections (SIs) in patients with RA treated with anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from the British Society for Rheumatology Biologics Register, a prospective observational study, we compared the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Galloway, James B., Hyrich, Kimme L., Mercer, Louise K., Dixon, William G., Fu, Bo, Ustianowski, Andrew P., Watson, Kath D., Lunt, Mark, Symmons, Deborah P. M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105607/
https://www.ncbi.nlm.nih.gov/pubmed/20675706
http://dx.doi.org/10.1093/rheumatology/keq242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105607/
https://www.ncbi.nlm.nih.gov/pubmed/20675706
http://dx.doi.org/10.1093/rheumatology/keq242

Ejemplares similares